However, these data suggest that in vivo sTWEAK might increase vascular MMP9 activity and thus initiate VC in normal phosphate conditions or worsen VC triggered by hyperphosphatemia, as observed in CKD. This evidence concerns the gene MMP9 and hyperphosphatemia.